Atlas Venture Fund XI, L.P.'s Net Worth
$314 Million
Who is Atlas Venture Fund XI, L.P.?
Atlas Venture Fund XI, L.P. has an estimated net worth of $314 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Akero Therapeutics, Inc., Ikena Oncology, Inc., Xilio Therapeutics, Inc., Third Harmonic Bio, Inc., and Korro Bio, Inc..
SEC CIK
Atlas Venture Fund XI, L.P.'s CIK is 0001708269
Past Insider Trading and Trends
2022 was Atlas Venture Fund XI, L.P.'s most active year for acquiring shares with 3 total transactions. Atlas Venture Fund XI, L.P.'s most active month to acquire stocks was the month of August. 2024 was Atlas Venture Fund XI, L.P.'s most active year for disposing of shares, totalling 18 transactions. Atlas Venture Fund XI, L.P.'s most active month to dispose stocks was the month of January. 2022 saw Atlas Venture Fund XI, L.P. paying a total of $5,100,000.00 for 7,366,470 shares, this is the most they've acquired in one year. In 2024 Atlas Venture Fund XI, L.P. cashed out on 1,631,865 shares for a total of $38,262,281.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.09% | -600.85K |
—
|
—
| 6.01M |
Scheduled
|
Dec 12
| ||
Form 4
| -8.33% | -600.85K |
—
|
—
| 6.61M |
Scheduled
|
Sep 19
| ||
Form 4
|
∞
| 766.67K |
$15.00 | $11,500,005.00 | 766.67K |
Jun 17
| |||
Form 4
| -10.00% | -801.14K |
—
|
—
| 7.21M |
Scheduled
|
Nov 24
| ||
Form 4
|
∞
| 9M |
$16.00 | $8,000,000.00 | 9M |
Feb 1 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.89% | -807.84K |
$24.32 | -$19,626,902.97 | 12.9M |
Scheduled
|
Feb 26 - Feb 28
| ||
Form 4
| -5.35% | -500.79K |
$22.68 | -$11,339,780.44 | 8.86M |
Scheduled
|
Feb 21 - Feb 23
| ||
Form 4
| -6.96% | -510.15K |
$23.26 | -$11,867,292.26 | 6.82M |
Scheduled
|
Feb 15 - Feb 20
| ||
Form 4
|
∞
| 934.58K |
$10.70 | $10,000,016.70 | 934.58K |
Dec 12
| |||
Form 4
| -10.00% | -814.01K |
—
|
—
| 7.33M |
Scheduled
|
Jul 13
| ||
Form 4
| +361.95% | 7.64M |
—
|
—
| 9.75M |
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $26.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.24% | -242.88K |
—
|
—
| 2.71M |
Scheduled
|
Dec 31
| ||
Form 4
| -14.36% | -570.97K |
—
|
—
| 3.4M |
Scheduled
|
Dec 17
| ||
Form 4
|
∞
| 3.97M |
$16.00 |
—
| 3.97M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ikena Oncology, Inc. (IKNA) Snapshot price: $1.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.89% | 98.72K |
$15.34 | $1,614,428.13 | 2.12M |
Mar 30 - Dec 14
| |||
Form 4
| +2,809.29% | 4.75M |
—
|
—
| 4.92M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.04% | -1.00K |
$0.64 | -$640.00 | 2.75M |
Feb 8
| |||
Form 4
| -0.15% | -4.24K |
$0.85 | -$3,600.45 | 2.76M |
Jan 11 - Jan 12
| |||
Form 4
| +10,385.82% | 2.73M |
$16.00 |
—
| 2.76M |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||